Gastrointestinal

Study: Fecal microbiota transplant effective in immunocompromised patients

Fecal microbiota transplant (FMT) for the treatment of Clostridium difficile infection in immunocompromised patients is safe and effective, according to a study in the American Journal of Gastroenterology. Read more and read an American Nurse Today article on FMT https://www.americannursetoday.com/fecal-microbiota-transplantation-breaking-the-chain-of-recurrent-c-difficile-infection/.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares